Top

Current Gastroenterology Reports

Published in:

01-04-2019 | Irritable Bowel Syndrome | Pediatric Gastroenterology (S Orenstein and S Khan, Section Editors)

Brain-Gut Therapies for Pediatric Functional Gastrointestinal Disorders and Inflammatory Bowel Disease

Authors: Hannibal Person, Laurie Keefer

Published in: Current Gastroenterology Reports | Issue 4/2019

Abstract

Purpose of Review

The purpose of this review is to discuss current knowledge of brain-gut therapies (BGT) in pediatric functional gastrointestinal disorders (FGID) and inflammatory bowel disease (IBD), including their evidence base, the common psychopathology that they address, and the integration of this knowledge into medical settings.

Recent Findings

Cognitive behavioral therapy (CBT), hypnotherapy (HT), mindfulness-based therapy (MBT), and exposure-based therapy (EBT) have the most data supporting their use in children, particularly in FGID, more so than in IBD. This difference is most likely because of the increased role of psychological factors in FGID, though these same factors can be seen comorbidly in IBD. Integrative BGT treatment strategies with the collaboration of clinicians across disciplines may provide the most benefit to patients.

Summary

This review details our current understanding of the evidence for BGT in pediatric FGID and IBD and how they may best be used in treatment strategies.

• Van Oudenhove L, Crowell MD, Drossman DA, Halpert AD, Keefer L, Lackner JM, et al. Biopsychosocial aspects of functional gastrointestinal disorders. Gastroenterology. 2016. https://doi.org/10.1053/j.gastro.2016.02.027. This is a review of our current understanding of the biopsychosocial mechanisms that create and maintain FGID. CrossRef

Bernstein CN. The brain-gut axis and stress in inflammatory bowel disease. Gastroenterol Clin N Am. 2017;46(4):839–46. https://doi.org/10.1016/j.gtc.2017.08.006.CrossRef

Khlevner J, Park Y, Margolis KG. Brain-gut axis: clinical implications. Gastroenterol Clin N Am. 2018;47(4):727–39. https://doi.org/10.1016/j.gtc.2018.07.002.CrossRef

Colombel JF, Shin A, Gibson PR. Functional gastrointestinal symptoms in patients with inflammatory bowel disease; Clin Gastroenterol Hepatol. 2018. https://doi.org/10.1016/j.cgh.2018.08.001.PubMed

• Watson KL Jr, Kim SC, Boyle BM, Saps M. Prevalence and impact of functional abdominal pain disorders in children with inflammatory bowel diseases (IBD-FAPD). J Pediatr Gastroenterol Nutr. 2017;65(2):212–7. https://doi.org/10.1097/MPG.0000000000001479. This is the first study to use Rome III criteria to assess the prevalence of FAP in pediatric IBD, also suggesting increased prevalence of mood symptoms in children with IBD-FAP. CrossRefPubMed

Chiou E, Nurko S. Functional abdominal pain and irritable bowel syndrome in children and adolescents. Therapy. 2011;8(3):315–31.CrossRef

Mackner LM, Greenley RN, Szigethy E, Herzer M, Deer K, Hommel KA. Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2013;56(4):449–58. https://doi.org/10.1097/MPG.0b013e3182841263.CrossRefPubMedPubMedCentral

Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54(10):1481–91. https://doi.org/10.1136/gut.2005.064261.CrossRefPubMedPubMedCentral

Bonney Reed-Knight LMM, Wallace V. Crandall Psychological aspects of inflammatory bowel disease in children and adolescents. Pediatric inflammatory bowel disease. New York: Springer International Publishing; 2017. p. 615–23.

10.

Levy RL, Whitehead WE, Walker LS, Von Korff M, Feld AD, Garner M, et al. Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol. 2004;99(12):2442–51. https://doi.org/10.1111/j.1572-0241.2004.40478.x.CrossRefPubMed

11.

Martin CR, Osadchiy V, Kalani A, Mayer EA. The brain-gut-microbiome Axis. Cell Mol Gastroenterol Hepatol. 2018;6(2):133–48. https://doi.org/10.1016/j.jcmgh.2018.04.003.CrossRefPubMedPubMedCentral

12.

Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381–96. https://doi.org/10.1146/annurev-med-012309-103958.CrossRefPubMed

13.

Campo JV, Bridge J, Ehmann M, Altman S, Lucas A, Birmaher B, et al. Recurrent abdominal pain, anxiety, and depression in primary care. Pediatrics. 2004;113(4):817–24.CrossRef

14.

Kilroy S, Nolan E, Sarma KM. Quality of life and level of anxiety in youths with inflammatory bowel disease in Ireland. J Pediatr Gastroenterol Nutr. 2011;53(3):275–9. https://doi.org/10.1097/MPG.0b013e318214c131.CrossRefPubMed

15.

Reigada LC, Hoogendoorn CJ, Walsh LC, Lai J, Szigethy E, Cohen BH, et al. Anxiety symptoms and disease severity in children and adolescents with Crohn disease. J Pediatr Gastroenterol Nutr. 2015;60(1):30–5. https://doi.org/10.1097/MPG.0000000000000552.CrossRefPubMed

16.

Clark JG, Srinath AI, Youk AO, Kirshner MA, McCarthy FN, Keljo DJ, et al. Predictors of depression in youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2014;58(5):569–73. https://doi.org/10.1097/MPG.0000000000000277.CrossRefPubMedPubMedCentral

17.

Benhayon D, Youk A, McCarthy FN, Davis S, Keljo DJ, Bousvaros A, et al. Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2013;57(3):335–42. https://doi.org/10.1097/MPG.0b013e31829641df.CrossRefPubMedPubMedCentral

18.

Beck AT. The past and future of cognitive therapy. J Psychother Pract Res. 1997;6(4):276–84.PubMedPubMedCentral

19.

White CA. Cognitive behavioral principles in managing chronic disease. West J Med. 2001;175(5):338–42.CrossRef

20.

Kinsinger SW. Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights. Psychol Res Behav Manag. 2017;10:231–7. https://doi.org/10.2147/PRBM.S120817.CrossRefPubMedPubMedCentral

21.

Galdston MR, John RM. Mind over gut: psychosocial management of pediatric functional abdominal pain. J Pediatr Health Care. 2016;30(6):535–45. https://doi.org/10.1016/j.pedhc.2015.11.011.CrossRefPubMed

22.

•• Bonnert M, Olen O, Lalouni M, Hedman-Lagerlof E, Sarnholm J, Serlachius E et al. Internet-delivered exposure-based cognitive-behavioral therapy for adolescents with functional abdominal pain or functional dyspepsia: a feasibility study. Behav Ther. 2019;50(1):177–88. https://doi.org/10.1016/j.beth.2018.05.002. This study demonstrates that internet-delivered EBT is beneficial in adolescents with FAP and FD. CrossRef

23.

Freeman KA, Riley A, Duke DC, Fu R. Systematic review and meta-analysis of behavioral interventions for fecal incontinence with constipation. J Pediatr Psychol. 2014;39(8):887–902. https://doi.org/10.1093/jpepsy/jsu039.CrossRefPubMed

24.

Slutsker B, Konichezky A, Gothelf D. Breaking the cycle: cognitive behavioral therapy and biofeedback training in a case of cyclic vomiting syndrome. Psychol Health Med. 2010;15(6):625–31. https://doi.org/10.1080/13548506.2010.498893.CrossRefPubMed

25.

van Tilburg MAL. Cognitive behavioral therapy for functional gastrointestinal disorders. In: Faure C, Thapar N, De Lorenzo C, editors. Pediatric neurogastroenterology. Cham, Springer; 2017. p. 507–13.

26.

Lackner JM, Jaccard J, Radziwon CD, Firth RS, Gudleski GD, Hamilton F, et al. Durability and decay of treatment benefit of cognitive behavioral therapy for irritable bowel syndrome: 12-month follow-up. Am J Gastroenterol. 2018. https://doi.org/10.1038/s41395-018-0396-x.CrossRef

27.

Bonnert M, Olen O, Lalouni M, Benninga MA, Bottai M, Engelbrektsson J, et al. Internet-delivered cognitive behavior therapy for adolescents with irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2017;112(1):152–62. https://doi.org/10.1038/ajg.2016.503.CrossRefPubMed

28.

Rathbone AL, Clarry L, Prescott J. Assessing the efficacy of mobile health apps using the basic principles of cognitive behavioral therapy: systematic review. J Med Internet Res. 2017;19(11):e399. https://doi.org/10.2196/jmir.8598.CrossRefPubMedPubMedCentral

29.

Szigethy E, Kenney E, Carpenter J, Hardy DM, Fairclough D, Bousvaros A, et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry. 2007;46(10):1290–8. https://doi.org/10.1097/chi.0b013e3180f6341f.CrossRefPubMed

30.

Szigethy E, Bujoreanu SI, Youk AO, Weisz J, Benhayon D, Fairclough D, et al. Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 2014;53(7):726–35. https://doi.org/10.1016/j.jaac.2014.04.014.CrossRefPubMedPubMedCentral

31.

Levy RL, van Tilburg MA, Langer SL, Romano JM, Walker LS, Mancl LA, et al. Effects of a cognitive behavioral therapy intervention trial to improve disease outcomes in children with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(9):2134–48. https://doi.org/10.1097/MIB.0000000000000881.CrossRefPubMedPubMedCentral

32.

•• Stapersma L, van den Brink G, van der Ende J, Szigethy EM, Beukers R, Korpershoek TA, et al. Effectiveness of disease-specific cognitive behavioral therapy on anxiety, depression, and quality of life in youth with inflammatory bowel disease: a randomized controlled trial. J Pediatr Psychol. 2018;43(9):967–80. https://doi.org/10.1093/jpepsy/jsy029. The most recent randomized control trial comparing disease-specific CBT to care as usual in pediatric IBD, suggesting no difference in improving psychological symptoms or HRQOL. CrossRefPubMed

33.

Ljotsson B, Hedman E, Andersson E, Hesser H, Lindfors P, Hursti T, et al. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol. 2011;106(8):1481–91. https://doi.org/10.1038/ajg.2011.139.CrossRefPubMed

34.

Lalouni M, Olen O, Bonnert M, Hedman E, Serlachius E, Ljotsson B. Exposure-based cognitive behavior therapy for children with abdominal pain: a pilot trial. PLoS One. 2016;11(10):e0164647. https://doi.org/10.1371/journal.pone.0164647.CrossRefPubMedPubMedCentral

35.

Brugnoli MP, Pesce G, Pasin E, Basile MF, Tamburin S, Polati E. The role of clinical hypnosis and self-hypnosis to relief pain and anxiety in severe chronic diseases in palliative care: a 2-year long-term follow-up of treatment in a nonrandomized clinical trial. Ann Palliat Med. 2018;7(1):17–31. https://doi.org/10.21037/apm.2017.10.03.CrossRefPubMed

36.

Del Casale A, Ferracuti S, Rapinesi C, De Rossi P, Angeletti G, Sani G, et al. Hypnosis and pain perception: an activation likelihood estimation (ALE) meta-analysis of functional neuroimaging studies. J Physiol Paris. 2015;109(4–6):165–72. https://doi.org/10.1016/j.jphysparis.2016.01.001.CrossRefPubMed

37.

Chiarioni G, Vantini I, De Iorio F, Benini L. Prokinetic effect of gut-oriented hypnosis on gastric emptying. Aliment Pharmacol Ther. 2006;23(8):1241–9. https://doi.org/10.1111/j.1365-2036.2006.02881.x.CrossRefPubMed

38.

Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res. 2004;56(3):271–8. https://doi.org/10.1016/S0022-3999(03)00076-X.CrossRefPubMed

39.

Riehl ME, Keefer L. Hypnotherapy for esophageal disorders. Am J Clin Hypn. 2015;58(1):22–33. https://doi.org/10.1080/00029157.2015.1025355.CrossRefPubMedPubMedCentral

40.

Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology. 2002;123(6):1778–85. https://doi.org/10.1053/gast.2002.37071.CrossRefPubMed

41.

Rutten JM, Vlieger AM, Frankenhuis C, George EK, Groeneweg M, Norbruis OF, et al. Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists. BMC Pediatr. 2014;14:140. https://doi.org/10.1186/1471-2431-14-140.CrossRefPubMedPubMedCentral

42.

Vlieger AM, Menko-Frankenhuis C, Wolfkamp SC, Tromp E, Benninga MA. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology. 2007;133(5):1430–6. https://doi.org/10.1053/j.gastro.2007.08.072.CrossRefPubMed

43.

van Tilburg MA, Chitkara DK, Palsson OS, Turner M, Blois-Martin N, Ulshen M, et al. Audio-recorded guided imagery treatment reduces functional abdominal pain in children: a pilot study. Pediatrics. 2009;124(5):e890–7. https://doi.org/10.1542/peds.2009-0028.CrossRefPubMed

44.

Weydert JA, Shapiro DE, Acra SA, Monheim CJ, Chambers AS, Ball TM. Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial. BMC Pediatr. 2006;6:29. https://doi.org/10.1186/1471-2431-6-29.CrossRefPubMedPubMedCentral

45.

• Vlieger AM, Rutten JM, Govers AM, Frankenhuis C, Benninga MA. Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol. 2012;107(4):627–31. https://doi.org/10.1038/ajg.2011.487. Randomized control trial suggesting that HT is more effective than supportive therapy in reducing pain and somatisization scores in pediatric FAP and IBS after 5 years of follow-up. CrossRefPubMed

46.

Szigethy E. Hypnotherapy for inflammatory bowel disease across the lifespan. Am J Clin Hypn. 2015;58(1):81–99. https://doi.org/10.1080/00029157.2015.1040112.CrossRefPubMed

47.

Shaoul R, Sukhotnik I, Mogilner J. Hypnosis as an adjuvant treatment for children with inflammatory bowel disease. J Dev Behav Pediatr. 2009;30(3):268. https://doi.org/10.1097/DBP.0b013e3181a7eeb0.CrossRefPubMed

48.

Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther. 2013;38(7):761–71. https://doi.org/10.1111/apt.12449.CrossRefPubMedPubMedCentral

49.

Mawdsley JE, Jenkins DG, Macey MG, Langmead L, Rampton DS. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol. 2008;103(6):1460–9. https://doi.org/10.1111/j.1572-0241.2008.01845.x.CrossRefPubMed

50.

Baer RA. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin Psychol Sci Pract. 2006.

51.

Ahola Kohut S, Stinson J, Davies-Chalmers C, Ruskin D, van Wyk M. Mindfulness-based interventions in clinical samples of adolescents with chronic illness: a systematic review. J Altern Complement Med. 2017;23(8):581–9. https://doi.org/10.1089/acm.2016.0316.CrossRefPubMed

52.

Korterink JJ, Ockeloen LE, Hilbink M, Benninga MA, Deckers-Kocken JM. Yoga therapy for abdominal pain-related functional gastrointestinal disorders in children: a randomized controlled trial. J Pediatr Gastroenterol Nutr. 2016;63(5):481–7. https://doi.org/10.1097/MPG.0000000000001230.CrossRefPubMed

53.

• Ali A, Weiss TR, Dutton A, McKee D, Jones KD, Kashikar-Zuck S, et al. Mindfulness-based stress reduction for adolescents with functional somatic syndromes: a pilot cohort study. J Pediatr. 2017;183:184–90. https://doi.org/10.1016/j.jpeds.2016.12.053. A pilot study introducing a MBSR program to a cohort of pediatric patients with functional somatic syndromes demonstrating improvements in functional disability, symptom impact, and anxiety. CrossRefPubMedPubMedCentral

54.

Garland EL, Gaylord SA, Palsson O, Faurot K, Douglas Mann J, Whitehead WE. Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. J Behav Med. 2012;35(6):591–602. https://doi.org/10.1007/s10865-011-9391-z.CrossRefPubMed

55.

Gaylord SA, Whitehead WE, Coble RS, Faurot KR, Palsson OS, Garland EL, et al. Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial. BMC Complement Altern Med. 2009;9:24. https://doi.org/10.1186/1472-6882-9-24.CrossRefPubMedPubMedCentral

56.

Cotton S, Humenay Roberts Y, Tsevat J, Britto MT, Succop P, McGrady ME, et al. Mind-body complementary alternative medicine use and quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16(3):501–6. https://doi.org/10.1002/ibd.21045.CrossRefPubMedPubMedCentral

57.

Neilson K, Ftanou M, Monshat K, Salzberg M, Bell S, Kamm MA, et al. A controlled study of a group mindfulness intervention for individuals living with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(3):694–701. https://doi.org/10.1097/MIB.0000000000000629.CrossRefPubMed

58.

•• Beinvogl B, Burch E, Snyder J, Schechter N, Hale A, Okazaki Y, et al. Multidisciplinary treatment of pediatric functional gastrointestinal disorders results in improved pain and functioning. Clin Gastroenterol Hepatol. 2018. https://doi.org/10.1016/j.cgh.2018.07.025. A single-site, retrospective observational cohort study of pediatric patients with FGID demonstrating the importance of comprehensive and multidisciplinary care. CrossRef

59.

Hechler T, Kanstrup M, Holley AL, Simons LE, Wicksell R, Hirschfeld G, et al. Systematic review on intensive interdisciplinary pain treatment of children with chronic pain. Pediatrics. 2015;136(1):115–27. https://doi.org/10.1542/peds.2014-3319.CrossRefPubMed

60.

Lalouni M, Ljotsson B, Bonnert M, Ssegonja R, Benninga M, Bjureberg J, et al. Clinical and cost effectiveness of online cognitive behavioral therapy in children with functional abdominal pain disorders. Clin Gastroenterol Hepatol. 2018. https://doi.org/10.1016/j.cgh.2018.11.043.

Title: Brain-Gut Therapies for Pediatric Functional Gastrointestinal Disorders and Inflammatory Bowel Disease
Authors: Hannibal Person
Laurie Keefer
Publication date: 01-04-2019
Publisher: Springer US
Keywords: Irritable Bowel Syndrome
Chronic Inflammatory Bowel Disease
Published in: Current Gastroenterology Reports / Issue 4/2019
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI: https://doi.org/10.1007/s11894-019-0683-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2019

Rectal Endoscopic Ultrasound in Clinical Practice

Gastric Neuroendocrine Tumors (Carcinoids)

Obesity, Motility, Diet, and Intestinal Microbiota—Connecting the Dots

Barrett’s Esophagus and Esophageal Carcinoma: Can Biomarkers Guide Clinical Practice?

Stem Cell Therapies for Inflammatory Bowel Disease

The Epidemiology of Hepatocellular Carcinoma in the USA

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage